No Dexamethasone Needed
Do not send this patient home on dexamethasone. Since your 84-year-old patient is saturating well on room air and does not require supplemental oxygen, corticosteroids are not indicated and may actually cause harm.
Clear Evidence Against Steroids Without Oxygen Requirement
The European Respiratory Society guidelines provide a strong recommendation (moderate quality evidence) that corticosteroids should NOT be offered to patients with COVID-19 requiring hospitalization but not requiring supplementary oxygen or ventilatory support 1. This is precisely your patient's situation.
Why This Matters for Mortality
The landmark RECOVERY trial, which forms the basis of current treatment guidelines, demonstrated critical differences based on oxygen requirements 2:
- Patients on invasive mechanical ventilation: 29.3% mortality with dexamethasone vs 41.4% without (significant benefit)
- Patients on oxygen without ventilation: 23.3% vs 26.2% (modest benefit)
- Patients NOT requiring oxygen: 17.8% mortality with dexamethasone vs 14.0% without (rate ratio 1.19,95% CI 0.92-1.55)
The data shows potential harm, not benefit, in patients without oxygen requirements. A post-hoc analysis calculated that dexamethasone in patients not requiring oxygen resulted in a number needed to harm (NNH) of 26.7 3.
Real-World Evidence Confirms This
A large Veterans Affairs study of nearly 20,000 hospitalized COVID-19 patients found that among those on no supplemental oxygen, early dexamethasone was associated with a 76% increased risk of 90-day mortality (HR 1.76,95% CI 1.47-2.12) 4. The authors explicitly concluded: "These real-world findings do not support the use of early dexamethasone in hospitalized COVID-19 patients without intensive respiratory support."
About the Resolved Lower Extremity Weakness
The transient lower extremity weakness that has completely resolved is not an indication for corticosteroids. This neurological symptom may have been:
- A transient COVID-19-related manifestation
- Unrelated to COVID-19
- Due to deconditioning or other causes
Since it has resolved and the patient has no respiratory compromise, there is no therapeutic rationale for steroids.
Common Pitfall to Avoid
Do not reflexively prescribe dexamethasone simply because the patient has COVID-19. The benefit of dexamethasone is specifically tied to the presence of hypoxemia requiring supplemental oxygen. Without this, you expose the patient to steroid-related risks (hyperglycemia, immunosuppression, potential secondary infections) without mortality benefit.
What This Patient Actually Needs
- Ensure appropriate anticoagulation prophylaxis (strong recommendation for all hospitalized COVID-19 patients) 1
- Monitor for clinical deterioration
- Discharge planning with clear return precautions if oxygen saturation drops or respiratory symptoms worsen
- Standard supportive care
The evidence is unequivocal: room air saturation = no dexamethasone.